| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kv1.3 Potassium Channel | 30 | 2023 | 36 | 4.180 |
Why?
|
| Potassium Channel Blockers | 27 | 2023 | 84 | 3.410 |
Why?
|
| Arthritis, Rheumatoid | 12 | 2023 | 262 | 2.200 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 8 | 2019 | 23 | 1.890 |
Why?
|
| Autoimmune Diseases | 10 | 2023 | 250 | 1.660 |
Why?
|
| Peptides | 14 | 2023 | 811 | 1.630 |
Why?
|
| T-Lymphocytes | 26 | 2019 | 1718 | 1.560 |
Why?
|
| Cnidarian Venoms | 9 | 2015 | 10 | 1.420 |
Why?
|
| Hypersensitivity, Delayed | 9 | 2017 | 35 | 1.340 |
Why?
|
| Scorpion Venoms | 9 | 2018 | 14 | 1.310 |
Why?
|
| Rats | 32 | 2023 | 3717 | 1.260 |
Why?
|
| Potassium Channels, Voltage-Gated | 10 | 2007 | 59 | 1.250 |
Why?
|
| Immunologic Memory | 13 | 2020 | 189 | 1.160 |
Why?
|
| Ion Channels | 5 | 2018 | 191 | 1.120 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 9 | 2012 | 35 | 1.040 |
Why?
|
| Dependovirus | 2 | 2023 | 128 | 0.920 |
Why?
|
| Matrix Metalloproteinases | 2 | 2017 | 67 | 0.880 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 314 | 0.870 |
Why?
|
| Animals | 57 | 2025 | 34210 | 0.740 |
Why?
|
| Sea Anemones | 4 | 2015 | 4 | 0.700 |
Why?
|
| Rats, Inbred Lew | 16 | 2019 | 68 | 0.690 |
Why?
|
| Probiotics | 1 | 2023 | 214 | 0.670 |
Why?
|
| Cell Movement | 5 | 2016 | 846 | 0.630 |
Why?
|
| Killer Cells, Natural | 2 | 2013 | 330 | 0.600 |
Why?
|
| Cell Separation | 3 | 2007 | 228 | 0.560 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 5 | 2013 | 14 | 0.550 |
Why?
|
| Myoblasts, Skeletal | 1 | 2016 | 12 | 0.540 |
Why?
|
| Spinal Cord | 2 | 2007 | 303 | 0.500 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 123 | 0.490 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 228 | 0.490 |
Why?
|
| Flow Cytometry | 5 | 2016 | 794 | 0.470 |
Why?
|
| Synoviocytes | 4 | 2019 | 4 | 0.470 |
Why?
|
| Fibroblasts | 7 | 2022 | 875 | 0.460 |
Why?
|
| Potassium Channels | 7 | 2004 | 157 | 0.450 |
Why?
|
| Multiple Sclerosis | 6 | 2011 | 329 | 0.440 |
Why?
|
| Cells, Cultured | 11 | 2019 | 3051 | 0.430 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 4390 | 0.430 |
Why?
|
| Models, Molecular | 9 | 2015 | 1080 | 0.430 |
Why?
|
| Th2 Cells | 1 | 2014 | 185 | 0.420 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 260 | 0.400 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2020 | 198 | 0.400 |
Why?
|
| Spleen | 2 | 2017 | 279 | 0.390 |
Why?
|
| Mice | 24 | 2025 | 17625 | 0.360 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2010 | 19 | 0.360 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1707 | 0.360 |
Why?
|
| Cell Line | 13 | 2017 | 2756 | 0.350 |
Why?
|
| Ovalbumin | 5 | 2017 | 319 | 0.350 |
Why?
|
| Adjuvants, Immunologic | 3 | 2007 | 383 | 0.340 |
Why?
|
| Interleukin-2 | 3 | 2007 | 244 | 0.340 |
Why?
|
| Synovial Membrane | 3 | 2015 | 27 | 0.330 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1895 | 0.330 |
Why?
|
| Patch-Clamp Techniques | 8 | 2018 | 282 | 0.330 |
Why?
|
| Protein Conformation | 9 | 2015 | 835 | 0.330 |
Why?
|
| Arthritis, Experimental | 3 | 2019 | 15 | 0.330 |
Why?
|
| Receptors, CCR7 | 7 | 2014 | 20 | 0.320 |
Why?
|
| Lymphocyte Activation | 9 | 2014 | 697 | 0.310 |
Why?
|
| Ion Channel Gating | 4 | 2013 | 122 | 0.300 |
Why?
|
| Kv1.1 Potassium Channel | 5 | 2015 | 36 | 0.290 |
Why?
|
| Hemocyanins | 1 | 2007 | 27 | 0.280 |
Why?
|
| Freund's Adjuvant | 1 | 2007 | 27 | 0.280 |
Why?
|
| Punctures | 1 | 2007 | 55 | 0.280 |
Why?
|
| Cell Division | 3 | 2007 | 782 | 0.280 |
Why?
|
| Biomedical Technology | 1 | 2007 | 36 | 0.280 |
Why?
|
| Saphenous Vein | 1 | 2007 | 60 | 0.280 |
Why?
|
| Blood Specimen Collection | 1 | 2007 | 48 | 0.280 |
Why?
|
| Amino Acid Sequence | 8 | 2015 | 2717 | 0.270 |
Why?
|
| Cell Membrane | 3 | 2016 | 462 | 0.270 |
Why?
|
| Humans | 41 | 2025 | 125014 | 0.270 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 141 | 0.260 |
Why?
|
| Asthma | 1 | 2014 | 755 | 0.260 |
Why?
|
| Up-Regulation | 2 | 2013 | 867 | 0.260 |
Why?
|
| Hepatocytes | 2 | 2025 | 208 | 0.250 |
Why?
|
| Calcium | 8 | 2018 | 1101 | 0.250 |
Why?
|
| Monocytes | 1 | 2007 | 345 | 0.250 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2016 | 97 | 0.240 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2004 | 12 | 0.230 |
Why?
|
| Genes, Essential | 1 | 2025 | 40 | 0.230 |
Why?
|
| Calcium Channels | 3 | 2015 | 160 | 0.230 |
Why?
|
| Cell Adhesion | 2 | 2017 | 344 | 0.230 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3892 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2025 | 177 | 0.220 |
Why?
|
| Mutation | 1 | 2018 | 5846 | 0.220 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 64 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2015 | 1698 | 0.220 |
Why?
|
| Toxins, Biological | 2 | 2015 | 69 | 0.220 |
Why?
|
| Fluoresceins | 1 | 2003 | 35 | 0.210 |
Why?
|
| Electrophysiology | 5 | 2014 | 271 | 0.210 |
Why?
|
| Neurotoxins | 3 | 2015 | 56 | 0.210 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 262 | 0.200 |
Why?
|
| Heart | 1 | 2007 | 728 | 0.200 |
Why?
|
| Immunity, Innate | 2 | 2016 | 373 | 0.200 |
Why?
|
| Terpenes | 3 | 2017 | 28 | 0.200 |
Why?
|
| Gene Editing | 2 | 2025 | 187 | 0.200 |
Why?
|
| Syndecan-2 | 1 | 2022 | 14 | 0.190 |
Why?
|
| Cell Proliferation | 8 | 2016 | 2308 | 0.190 |
Why?
|
| TRPV Cation Channels | 2 | 2015 | 33 | 0.190 |
Why?
|
| Receptors, Chemokine | 3 | 2013 | 44 | 0.190 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 1399 | 0.180 |
Why?
|
| Pancreatitis-Associated Proteins | 2 | 2013 | 10 | 0.180 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 108 | 0.180 |
Why?
|
| Lung Injury | 1 | 2022 | 122 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2015 | 77 | 0.170 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2019 | 29 | 0.160 |
Why?
|
| Liver | 2 | 2025 | 1743 | 0.160 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 63 | 0.160 |
Why?
|
| Proteins | 3 | 2014 | 1036 | 0.160 |
Why?
|
| Brain | 2 | 2007 | 2999 | 0.150 |
Why?
|
| Immunosuppressive Agents | 3 | 2012 | 650 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 818 | 0.150 |
Why?
|
| Interleukin-10 | 2 | 2023 | 174 | 0.150 |
Why?
|
| Phenotype | 5 | 2018 | 4259 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2017 | 327 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 43 | 0.140 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 113 | 0.140 |
Why?
|
| Emulsions | 2 | 2007 | 69 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2014 | 292 | 0.140 |
Why?
|
| Arthritis | 2 | 2015 | 80 | 0.140 |
Why?
|
| Integrin beta1 | 1 | 2017 | 56 | 0.140 |
Why?
|
| Testicular Diseases | 1 | 2016 | 11 | 0.140 |
Why?
|
| Cell Fusion | 1 | 2016 | 37 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2017 | 79 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 345 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2016 | 49 | 0.130 |
Why?
|
| Inflammation | 2 | 2023 | 1443 | 0.130 |
Why?
|
| Kinetics | 3 | 2015 | 1332 | 0.130 |
Why?
|
| Antigens | 3 | 2007 | 156 | 0.130 |
Why?
|
| Female | 22 | 2019 | 66709 | 0.130 |
Why?
|
| Peptide Fragments | 3 | 2015 | 780 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2020 | 937 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 94 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 361 | 0.130 |
Why?
|
| Learning | 1 | 2019 | 360 | 0.130 |
Why?
|
| Adoptive Transfer | 3 | 2007 | 235 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 702 | 0.120 |
Why?
|
| Time Factors | 4 | 2007 | 6326 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 361 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 573 | 0.120 |
Why?
|
| Disulfides | 2 | 2005 | 79 | 0.120 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Myelin Basic Protein | 3 | 2004 | 68 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 256 | 0.120 |
Why?
|
| Calcium Signaling | 2 | 2014 | 243 | 0.120 |
Why?
|
| Protein Stability | 2 | 2014 | 161 | 0.120 |
Why?
|
| Myotonic Dystrophy | 1 | 2016 | 149 | 0.120 |
Why?
|
| Allergens | 1 | 2017 | 252 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2015 | 266 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2015 | 114 | 0.120 |
Why?
|
| Injections, Subcutaneous | 3 | 2017 | 130 | 0.110 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 2521 | 0.110 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 22 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2016 | 459 | 0.110 |
Why?
|
| Interleukin-5 | 1 | 2014 | 43 | 0.110 |
Why?
|
| Protein Engineering | 2 | 2011 | 73 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 106 | 0.110 |
Why?
|
| Drug Design | 1 | 2015 | 152 | 0.110 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2013 | 10 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2014 | 140 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 150 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 232 | 0.110 |
Why?
|
| Antioxidants | 1 | 2016 | 369 | 0.110 |
Why?
|
| Helminths | 1 | 2014 | 48 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2014 | 97 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 625 | 0.110 |
Why?
|
| Cell Degranulation | 1 | 2013 | 29 | 0.110 |
Why?
|
| K562 Cells | 1 | 2013 | 95 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 388 | 0.110 |
Why?
|
| Cytokines | 4 | 2023 | 1285 | 0.110 |
Why?
|
| Neural Conduction | 2 | 2004 | 92 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 313 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2013 | 116 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 2014 | 144 | 0.100 |
Why?
|
| Interleukin-15 | 1 | 2013 | 87 | 0.100 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2015 | 167 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 769 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 206 | 0.100 |
Why?
|
| Pichia | 1 | 2012 | 56 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 307 | 0.100 |
Why?
|
| Pyrazoles | 2 | 2013 | 305 | 0.100 |
Why?
|
| Thioredoxins | 1 | 2012 | 25 | 0.100 |
Why?
|
| Synovial Fluid | 1 | 2011 | 15 | 0.100 |
Why?
|
| Rheumatic Fever | 1 | 2011 | 18 | 0.090 |
Why?
|
| Young Adult | 2 | 2017 | 9045 | 0.090 |
Why?
|
| Obesity | 1 | 2023 | 2247 | 0.090 |
Why?
|
| Transgenes | 2 | 2025 | 336 | 0.090 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2011 | 31 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 659 | 0.090 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2010 | 15 | 0.090 |
Why?
|
| Acrylic Resins | 1 | 2010 | 25 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 651 | 0.090 |
Why?
|
| Guinea Pigs | 4 | 2003 | 167 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2011 | 174 | 0.080 |
Why?
|
| Middle Aged | 6 | 2017 | 26918 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2017 | 381 | 0.080 |
Why?
|
| Binding, Competitive | 2 | 2012 | 192 | 0.080 |
Why?
|
| Neoplasms | 2 | 2014 | 2786 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2014 | 675 | 0.080 |
Why?
|
| Adult | 6 | 2017 | 29620 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2007 | 125 | 0.080 |
Why?
|
| Ear, External | 1 | 2008 | 22 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3741 | 0.080 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 38 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 1 | 2008 | 117 | 0.070 |
Why?
|
| Shab Potassium Channels | 1 | 2007 | 2 | 0.070 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2007 | 5 | 0.070 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2007 | 5 | 0.070 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2007 | 3 | 0.070 |
Why?
|
| HEK293 Cells | 3 | 2019 | 736 | 0.070 |
Why?
|
| Concanavalin A | 1 | 2007 | 16 | 0.070 |
Why?
|
| Mitogens | 1 | 2007 | 31 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 766 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2012 | 392 | 0.070 |
Why?
|
| Blood Cells | 1 | 2007 | 50 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2005 | 237 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2007 | 32 | 0.070 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 233 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 1241 | 0.070 |
Why?
|
| Dermatitis | 1 | 2007 | 26 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3156 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2007 | 111 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 488 | 0.070 |
Why?
|
| Calcium Channel Blockers | 2 | 2004 | 115 | 0.070 |
Why?
|
| Immunization | 2 | 2020 | 307 | 0.070 |
Why?
|
| Structure-Activity Relationship | 3 | 2015 | 581 | 0.070 |
Why?
|
| Optic Nerve | 2 | 2004 | 114 | 0.060 |
Why?
|
| Protein Binding | 3 | 2015 | 1757 | 0.060 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2005 | 14 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 503 | 0.060 |
Why?
|
| Male | 10 | 2019 | 61429 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3570 | 0.060 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2004 | 12 | 0.060 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2004 | 12 | 0.060 |
Why?
|
| Hydrolases | 1 | 2025 | 55 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 663 | 0.060 |
Why?
|
| Synaptosomes | 1 | 2004 | 31 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2005 | 172 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 49 | 0.060 |
Why?
|
| Furocoumarins | 1 | 2004 | 3 | 0.060 |
Why?
|
| Static Electricity | 1 | 2004 | 45 | 0.060 |
Why?
|
| Elapid Venoms | 1 | 2004 | 8 | 0.060 |
Why?
|
| Lymphocytes | 2 | 2004 | 410 | 0.060 |
Why?
|
| Action Potentials | 2 | 2004 | 502 | 0.060 |
Why?
|
| Gene Expression | 2 | 2020 | 1561 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2004 | 122 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2015 | 104 | 0.050 |
Why?
|
| Magnesium | 1 | 2023 | 123 | 0.050 |
Why?
|
| Biotin | 1 | 2003 | 45 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 1195 | 0.050 |
Why?
|
| Th17 Cells | 1 | 2023 | 90 | 0.050 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2022 | 4 | 0.050 |
Why?
|
| Citrullination | 1 | 2022 | 6 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2003 | 472 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4403 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2003 | 150 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2022 | 41 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 153 | 0.050 |
Why?
|
| DNA Repair | 1 | 2025 | 585 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 218 | 0.050 |
Why?
|
| Binding Sites | 2 | 2015 | 1303 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 355 | 0.040 |
Why?
|
| Collagen | 2 | 2015 | 318 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 1583 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 1016 | 0.040 |
Why?
|
| COS Cells | 2 | 2012 | 275 | 0.040 |
Why?
|
| Gene Order | 1 | 2020 | 79 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2003 | 680 | 0.040 |
Why?
|
| Amino Acids | 1 | 2003 | 667 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 335 | 0.040 |
Why?
|
| Scorpions | 2 | 2012 | 5 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 329 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 10 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 2906 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 26 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 29 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 74 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 104 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 174 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2018 | 196 | 0.040 |
Why?
|
| Isotope Labeling | 2 | 2012 | 104 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 774 | 0.040 |
Why?
|
| Arteries | 1 | 2018 | 224 | 0.030 |
Why?
|
| Aging | 1 | 2004 | 1184 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2018 | 150 | 0.030 |
Why?
|
| Nanoconjugates | 1 | 2016 | 2 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2016 | 7 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 143 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2018 | 270 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2016 | 15 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 47 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 2397 | 0.030 |
Why?
|
| Cannabidiol | 1 | 2015 | 22 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 69 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 359 | 0.030 |
Why?
|
| Cannabinoids | 1 | 2015 | 31 | 0.030 |
Why?
|
| Drosophila | 1 | 2019 | 774 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2015 | 118 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 231 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2821 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1497 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2014 | 165 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1103 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 864 | 0.030 |
Why?
|
| Indoles | 1 | 2015 | 189 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 499 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2013 | 144 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 404 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 659 | 0.030 |
Why?
|
| Metabolomics | 1 | 2016 | 423 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4531 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 176 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2005 | 979 | 0.030 |
Why?
|
| Saimiri | 1 | 2012 | 11 | 0.030 |
Why?
|
| Absorption | 1 | 2012 | 52 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2012 | 71 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 43 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2012 | 63 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 399 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 87 | 0.020 |
Why?
|
| Amides | 1 | 2012 | 89 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 45 | 0.020 |
Why?
|
| Gelatinases | 1 | 2011 | 15 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2011 | 25 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 696 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 216 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3298 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 657 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2011 | 43 | 0.020 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2011 | 21 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 24 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2011 | 12 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3079 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2011 | 23 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 125 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2011 | 61 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 209 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 308 | 0.020 |
Why?
|
| Vaccination | 1 | 2015 | 960 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 409 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 522 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2013 | 875 | 0.020 |
Why?
|
| Chlamydia trachomatis | 1 | 2008 | 25 | 0.020 |
Why?
|
| Xanthenes | 1 | 2008 | 7 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 432 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 259 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2008 | 51 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 698 | 0.020 |
Why?
|
| Chlamydia Infections | 1 | 2008 | 49 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 2008 | 38 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2008 | 59 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 702 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 985 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2008 | 379 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 19854 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1629 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 3345 | 0.020 |
Why?
|
| Skin | 1 | 2008 | 518 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 1501 | 0.010 |
Why?
|
| Cnidaria | 1 | 2003 | 2 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2003 | 46 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2003 | 91 | 0.010 |
Why?
|
| Thymidine | 1 | 2001 | 54 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 330 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 173 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1694 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 4811 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 25 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2001 | 92 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 397 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6595 | 0.010 |
Why?
|
| Child | 1 | 2019 | 24339 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 682 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 10282 | 0.010 |
Why?
|